PDS Biotechnology Corporation
VACCINE COMPOSITIONS AND METHODS OF USE
Last updated:
Abstract:
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
Status:
Application
Type:
Utility
Filling date:
22 Jul 2021
Issue date:
25 Nov 2021